MOFs have a low density and large internal surface area, allowing for the incorporation of numerous antioxidant agents [312]
Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management
Nicotinamide mononucleotide (NMN), a precursor of NAD+, effectively restores intracellular redox imbalance induced by UVB radiation in keratinocytes
Enhanced Detoxification Support: As the primary detoxifier in the liver, glutathione helps eliminate toxins, heavy metals, and harmful substances from the body, supporting overall liver health and function
Recent Findings Preliminary data suggest that GLP-1 RA can modulate crucial pathways in the pathogenesis of IBD, such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity